Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NØRAGER FYSIOTERAPI ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.7% 2.7% 7.7% 3.6% 7.3% 5.5% 17.5% 17.2%   Credit score (0-100)   62 61 32 51 33 35 9 10   Credit rating   BBB BBB BB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,101 1,725 2,000 2,871 3,086 2,664 0.0 0.0   EBITDA   391 381 -16.7 507 166 199 0.0 0.0   EBIT   298 369 -34.1 482 144 187 0.0 0.0   Pre-tax profit (PTP)   300.3 370.8 -39.0 478.1 137.0 185.0 0.0 0.0   Net earnings   234.1 289.1 -31.1 372.7 105.8 145.9 0.0 0.0   Pre-tax profit without non-rec. items   300 371 -39.0 478 137 185 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   49.7 37.1 84.8 60.3 38.2 26.1 0.0 0.0   Shareholders equity total   540 629 18.9 392 167 196 0.9 0.9   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   989 1,065 786 1,014 705 637 0.9 0.9   Net Debt   -405 -553 -231 -496 -157 -195 -0.9 -0.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,101 1,725 2,000 2,871 3,086 2,664 0.0 0.0   Gross profit growth   -8.3% -17.9% 16.0% 43.5% 7.5% -13.7% -100.0% 0.0%   Employees   6 6 6 7 7 6 0 0   Employee growth %   -14.3% 0.0% 0.0% 16.7% 0.0% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   989 1,065 786 1,014 705 637 1 1   Balance sheet change%   51.8% 7.7% -26.2% 29.0% -30.5% -9.6% -99.9% 0.0%   Added value   390.7 381.5 -16.7 506.7 168.0 199.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -186 -25 30 -49 -44 -24 -26 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.2% 21.4% -1.7% 16.8% 4.7% 7.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.7% 36.1% -3.6% 53.6% 16.7% 27.9% 0.0% 0.0%   ROI %   70.8% 63.5% -10.4% 235.0% 51.4% 103.2% 0.0% 0.0%   ROE %   55.4% 49.5% -9.6% 181.6% 37.8% 80.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   54.6% 59.0% 2.4% 38.6% 23.7% 30.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -103.7% -145.1% 1,381.5% -97.9% -94.7% -97.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 2.2 0.8 1.4 1.1 1.3 0.0 0.0   Current Ratio   2.1 2.4 0.9 1.5 1.2 1.4 0.0 0.0   Cash and cash equivalent   405.0 553.5 231.1 496.2 156.8 194.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   490.1 591.8 -65.9 331.2 129.1 169.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   65 64 -3 72 24 33 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   65 64 -3 72 24 33 0 0   EBIT / employee   50 61 -6 69 21 31 0 0   Net earnings / employee   39 48 -5 53 15 24 0 0